{"pageContent": "Prostate cancer is the most common nonskin cancer diagnosed in U.S. men and kills over 27 000 men annually. Thus, improving the outcomes for patients diagnosed with this disease is imperative. There has been a considerable amount of research done over the past several decades resulting in more cures than ever, but the death rate is still unacceptable. This oration addresses the progress that we have made over the past several decades and outlines the work yet to be done, as well as some processes to make that work happen. \u00a9 RSNA, 2018.", "metaData": {"source": "[Is it beneficial to operate a localized prostate cancer?]\nhttps://pubmed.ncbi.nlm.nih.gov/12815979/"}}